Back
Global Indemnity Group LLC Vs. Madrigal Pharmaceuticals Industry Stock Comparison
Buy
79
GBLI
Global Indemnity Group LLC
Last Price:
33.53
Seasonality Move:
7.91%
Buy
71
MDGL
Madrigal Pharmaceuticals
Last Price:
305.34
Seasonality Move:
31.67%
Buy
79
Global Indemnity Group LLC (GBLI)
is a Buy
Is Global Indemnity Group LLC a Buy, Sell or Hold?
- The current Global Indemnity Group LLC [GBLI] share price is $33.98. The Score for GBLI is 79, which is 58% above its historic median score of 50, and infers lower risk than normal.
- GBLI is currently trading in the 70-80% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
Buy
71
Madrigal Pharmaceuticals (MDGL)
is a Buy
Is Madrigal Pharmaceuticals a Buy, Sell or Hold?
- The current Madrigal Pharmaceuticals [MDGL] share price is $259.34. The Score for MDGL is 71, which is 42% above its historic median score of 50, and infers lower risk than normal.
- MDGL is currently trading in the 70-80% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
GBLI Stock Price Chart
What is Global Indemnity Group LLC's stock price today?
-
The Global Indemnity Group LLC share price today is $33.98
Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and GBLI is experiencing selling pressure, which indicates risk of future bearish movement.
MDGL Stock Price Chart
What is Madrigal Pharmaceuticals's stock price today?
-
The Madrigal Pharmaceuticals share price today is $259.34
Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and MDGL is experiencing buying pressure, which is a positive indicator for future bullish movement.
GBLI Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | 0.3 | Buy |
| Relative Strength Index (14 RSI): | 56.82 | Buy |
| Chaikin Money Flow: | -916 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (33.22 - 34.16) | Buy |
| Bollinger Bands (100): | (30.8 - 33.22) | Buy |
MDGL Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | 0.45 | Buy |
| Relative Strength Index (14 RSI): | 74.74 | Buy |
| Chaikin Money Flow: | 898979 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (203.29 - 223.91) | Buy |
| Bollinger Bands (100): | (221.8 - 277.54) | Buy |
GBLI Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 33.98 | Sell |
| 20-day SMA: | 33.86 | Buy |
| 50-day SMA: | 33 | Buy |
| 200-day SMA: | 31.26 | Buy |
| 8-day EMA: | 33.96 | Buy |
| 20-day EMA: | 33.75 | Buy |
| 50-day EMA: | 33.09 | Buy |
| 200-day EMA: | 31.92 | Buy |
MDGL Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 216.22 | Buy |
| 20-day SMA: | 214.16 | Buy |
| 50-day SMA: | 227.04 | Buy |
| 200-day SMA: | 240.71 | Buy |
| 8-day EMA: | 223.2 | Buy |
| 20-day EMA: | 218.42 | Buy |
| 50-day EMA: | 226.38 | Buy |
| 200-day EMA: | 233.63 | Buy |
Global Indemnity Group LLC Earnings Growth & GBLI Earnings Dates
- Analysts estimate an earnings decrease this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.01 per share, and an increase next year of $0.14 per share.
Madrigal Pharmaceuticals Earnings Growth & MDGL Earnings Dates
- Analysts estimate an earnings decrease this quarter of $2.71 per share, a decrease next quarter of $0.00 per share, a decrease this year of $7.95 per share, and an increase next year of $9.71 per share.
Global Indemnity Group LLC Technical Analysis
| Oct 18 | Oct 21 | Oct 22 | Oct 23 | Oct 24 | Oct 25 | Oct 28 | Oct 29 | Oct 30 | Oct 31 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Oct | ||||||||||
| 18 | 21 | 22 | 23 | 24 | 25 | 28 | 29 | 30 | 31 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
Madrigal Pharmaceuticals Technical Analysis
| Oct 18 | Oct 21 | Oct 22 | Oct 23 | Oct 24 | Oct 25 | Oct 28 | Oct 29 | Oct 30 | Oct 31 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Oct | ||||||||||
| 18 | 21 | 22 | 23 | 24 | 25 | 28 | 29 | 30 | 31 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||